|
Basis of Presentation (Details 2) (USD $)
In Thousands, except Per Share data, unless otherwise specified |
0 Months Ended | 1 Months Ended | 6 Months Ended | 1 Months Ended | 1 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Jun. 02, 2014
|
Apr. 07, 2014
|
Jun. 30, 2014
|
Jun. 30, 2014
|
Jun. 30, 2013
|
Jun. 26, 2014
Common Stock [Member]
|
Jun. 30, 2014
Common Stock [Member]
Fosun Pharma [Member]
|
Jun. 26, 2014
Common Stock [Member]
Fosun Pharma [Member]
|
Jun. 30, 2014
China Joint Venture [Member]
|
Jun. 30, 2014
China Joint Venture [Member]
Fosun Pharma [Member]
|
Jun. 26, 2014
China Joint Venture [Member]
Fosun Pharma [Member]
item
|
|
| Strategic Allliance and Formation of China Joint Venture [Line Items] | |||||||||||
| Proceeds from Issuance of Private Placement | $ 46,300 | ||||||||||
| Dividends Payable, Amount Per Share | $ 1.50 | ||||||||||
| Dividends payable to shareholders | 29,000 | ||||||||||
| Payments of Dividends | 1,619 | 1,618 | 3,237 | 3,170 | |||||||
| Shares, Issued | 2,860 | ||||||||||
| Share Price | $ 16.19 | ||||||||||
| Premium to Entity Average Stock Price for the Trailing Thirty Day Period | 10.00% | ||||||||||
| Period of Time to Measure Premium of Entity Common Stock | 30 days | ||||||||||
| Related Party Ownership Percentage After Common Stock Purchase | 15.00% | ||||||||||
| Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions | 80.00% | 20.00% | |||||||||
| Initial Capitalization Amount | $ 16,000 | $ 4,000 | |||||||||
| Number of Board of Directors Initially Appointed | 1 | ||||||||||